title: Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial.
authors.forename: Oliver
authors.initials: O
authors.lastname: Gaemperli
authors.forename: Tiziano
authors.initials: T
authors.lastname: Schepis
authors.forename: Pascal
authors.initials: P
authors.lastname: Koepfli
authors.forename: Patrick T
authors.initials: PT
authors.lastname: Siegrist
authors.forename: Samuel
authors.initials: S
authors.lastname: Fleischman
authors.forename: Patricia
authors.initials: P
authors.lastname: Nguyen
authors.forename: Ann
authors.initials: A
authors.lastname: Olmsted
authors.forename: Whedy
authors.initials: W
authors.lastname: Wang
authors.forename: Hsiao
authors.initials: H
authors.lastname: Lieu
authors.forename: Philipp A
authors.initials: PA
authors.lastname: Kaufmann
mesh_terms: D058908:Adenosine A2 Receptor Agonists; D058917:Adenosine A2 Receptor Antagonists; D002110:Caffeine / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004347:Drug Interactions; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D049268:Positron-Emission Tomography; D011687:Purines / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
chemical_list: D058908:Adenosine A2 Receptor Agonists; D058917:Adenosine A2 Receptor Antagonists; D011687:Purines; D011720:Pyrazoles; D014665:Vasodilator Agents; C430916:regadenoson; D002110:Caffeine